Based on its physiological functions against major proto-oncogenic pathways driven by Wnt/β-catenin, hedgehog, notch and c-Myc signaling, as well as against epithelial-to-mesenchymal transition, GSK3β has long been recognized to suppress tumor development and progression18,22. This evidence concerns the gene MYC and neoplasm.